Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Discipline keeps budgets on track amid temptations to overspend. Learn why steady habits matter and how to cultivate them for lasting budgeting success.
23,814 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
A china tech fund opens a biotech position, signaling a broader shift toward life sciences within tech-driven portfol...
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
A morning surge in AeroVironment stock popped today after reports of potential U.S. drone subsidies. This guide unpac...
A celebrity-led passion project climbs to the top on Apple TV, proving that owning your story and diversifying income...
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
Oklo is developing compact nuclear reactors geared for AI data centers. This article lays out a grounded five-year ro...
NVIDIA’s push beyond chips is drawing investor attention to life sciences. This article breaks down what Jensen Huang...
When a biotech deal moves a small cap, it can set the tone for the whole sector. This story explains what happened wi...
A major biotech acquisition news drove a sharp move in ATAI shares. This article breaks down why ataibeckley stock so...
If you’re worried about stock market volatility, defensive dividend stocks can help. This guide covers smart picks, s...
Looking for fast-growing industrial mid-cap stocks with durable revenue streams? This guide breaks down two compellin...